← Leaderboards
David Van Buren
Vanderbilt University
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Barney S Graham$269,836
- Richard N Pierson$28,134,227
- Mikhail M Dikov$4,391,433
- Kelly A Birdwell$3,186,569
- Nancy J Olsen$6,548,556
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDrug Administration Rate /DurationDrug Screening /EvaluationHomologous TransplantationHuman SubjectHuman Therapy EvaluationImmunosuppressionImmunosuppressiveKidney TransplantationMycophenolate MofetilTransplant Rejection
Grant awards (5)
EFFICACY AND SAFETY OF SDZ RAD DE NOVO RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2002 · RR
EFFICACY AND SAFETY OF SDZ RAD DE NOVO RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2001 · RR
EFFICACY AND SAFETY OF SDZ RAD DE NOVO RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2001 · RR
EFFICACY AND SAFETY OF SDZ RAD DE NOVO RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2001 · RR
EFFICACY AND SAFETY OF SDZ RAD DE NOVO RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2000 · RR